Detalles de la búsqueda
1.
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study.
Diabetes Obes Metab
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38853712
2.
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Nutr Metab Cardiovasc Dis
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693036
3.
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study.
Nutr Metab Cardiovasc Dis
; 33(11): 2294-2305, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37679243
4.
Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins.
Nutr Metab Cardiovasc Dis
; 32(9): 2255-2263, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961826
5.
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study.
Diabetes Metab Res Rev
; 36(6): e3304, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32118347
6.
Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT study.
Nutr Metab Cardiovasc Dis
; 30(11): 1937-1944, 2020 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32912786
7.
Corrigendum to Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins > Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2255-2263.
Nutr Metab Cardiovasc Dis
; 33(4): 920-921, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948942
8.
Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis.
Diabetes Obes Metab
; 24(2): 327-331, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34595824
9.
Effectiveness of switching from first-generation basal insulin to Glargine 300 U/mL in children and adolescents with type 1 diabetes: results from the ISPED CARD database.
Acta Diabetol
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38789610
10.
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.
Diabetes Ther
; 14(1): 77-92, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36376644
11.
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY).
Acta Diabetol
; 59(10): 1317-1330, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864262
12.
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study.
Diabetes Ther
; 12(2): 509-525, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33351177
13.
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study.
Diabetes Ther
; 11(10): 2283-2298, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32813262
14.
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.
BMC Microbiol
; 8: 23, 2008 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-18230154
15.
An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
Int J Antimicrob Agents
; 30(4): 374-6, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17659863
16.
Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study.
Diagn Microbiol Infect Dis
; 69(4): 363-9, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21396530
17.
Time-kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion.
J Antimicrob Chemother
; 52(6): 1047-8, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14585860
Resultados
1 -
17
de 17
1
Próxima >
>>